We are live on
!
Find out more
MIP
Mondrian Investment Partners Portfolio holdings
AUM
$6.69B
This Fund
S&P 500
This Quarter
Est. Return
-0.72%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.21B
AUM Growth
-$993M
(-14%)
Cap. Flow
-$316M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
51.3%
Holding
90
New
2
Increased
22
Reduced
34
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$67.9M |
| 2 |
CAE Inc. Common Shares
CAE
|
+$39.1M |
| 3 |
Avery Dennison
AVY
|
+$23.6M |
| 4 |
BSMX
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
|
+$20.7M |
| 5 |
Ambev
ABEV
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$273M |
| 2 |
Conagra Brands
CAG
|
+$54.8M |
| 3 |
Infosys
INFY
|
+$41.1M |
| 4 |
IBM
IBM
|
+$34M |
| 5 |
Ingredion
INGR
|
+$25.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.81% |
| 2 | Financials | 14.06% |
| 3 | Technology | 12.99% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Utilities | 11.22% |
Similar funds
MSE
FLPIM
TB
AG
BHM
SPS
SPC
TAM
Mondrian Investment Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Mondrian Investment Partners held 90 positions worth $6.21B, down 14% from $7.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Mondrian Investment Partners withdrew a net $316M in Q4 2014, reducing 34 holdings. Its largest reduction was Teva Pharmaceuticals, cutting an estimated $273M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Mondrian Investment Partners opened a new position in Mastercard worth $18.5M.
- Mondrian Investment Partners's largest Q4 2014 buy was Mastercard: 214,800 shares worth $18.5M.
- Mondrian Investment Partners added most to Pfizer in Q4 2014, an estimated $67.9M increase.
- Mondrian Investment Partners's biggest Q4 2014 reduction was Teva Pharmaceuticals, cutting an estimated $273M.
- Mondrian Investment Partners's ten largest holdings make up 51% of its $6.21B portfolio in Q4 2014.
- Mondrian Investment Partners opened 2 new positions and closed 0 in Q4 2014.
- Mondrian Investment Partners's portfolio value fell 14% quarter-over-quarter to $6.21B.
Based on Mondrian Investment Partners's 13F filing for Q4 2014, filed 27 Jan 2015.